Norway excludes AstraZeneca from vaccination campaign, says PM Erna Solberg

Norway has removed the vaccine against Covid-19 made by AstraZeneca from its inoculation campaign, Prime Minister Erna Solberg said.

AstraZeneca, pharma, coronavirus, vaccine
IANS Copenhagen
1 min read Last Updated : May 13 2021 | 9:45 AM IST

Norway has removed the vaccine against Covid-19 made by AstraZeneca from its inoculation campaign, Prime Minister Erna Solberg said.

Solberg said on Wednesday that the decision was based on the advice of a committee of experts and the Norwegian Institute of Public Health (FHI), which recommended excluding the shots made by AstraZeneca and Johnson & Johnson due to the risk of very rare but serious side effects, DPA news agency reported.

Norway is also extending its temporary halt on the use of the Johnson & Johnson shot, but has not excluded it from its inoculation campaign for now, Solberg said.

The government is currently looking into offering the Johnson & Johnson vaccine to those willing to receive it.

The country had not yet started using the Johnson & Johnson jab.

The committee's recommendations were based partly on the current situation in Norway, where infections are low compared to other countries.

Norway stopped using the Astrazeneca's vaccine on March 11 as a precautionary measure after rare blood clots occurred after vaccination, including deaths. Some 138,000 people had received the vaccine up until then.

Denmark excluded the AstraZeneca vaccine from its inoculation programme just over a month ago.

--IANS

int/pgh

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :NorwayAstraZenecaCoronavirus Vaccine

First Published: May 13 2021 | 9:35 AM IST

Next Story